Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Vey

Showing results (191-200 of 251) with videos related to

Pageof 26
Sort By:
Leukemia Research|December 20, 2014
Azacitidine for the treatment of relapsed and refractory AML in older patientsRaphael Itzykson, Sylvain Thépot, Céline Berthon, et al.
The New England Journal of Medicine|September 15, 2016
Rituximab in B-Lineage Adult Acute Lymphoblastic LeukemiaSébastien Maury, Sylvie Chevret, Xavier Thomas, et al.
Blood Cancer Journal|January 27, 2022
Clinico-biological features of T-cell acute lymphoblastic leukemia with fusion proteinsThomas Steimlé, Marie-Emilie Dourthe, Marion Alcantara, et al.
European Journal of Haematology|March 18, 2021
Conventional chemotherapy for acute myeloid leukemia in older adults: Impact on nutritional, cognitive, and functional statusClaire Jouzier, Jean-François Hamel, Pierre-Yves Dumas, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 26, 2019
Thiotepa, Fludarabine, and Busulfan Conditioning Regimen before T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia: A Bicentric Experience of 100 PatientsThomas Pagliardini, Lucas Castagna, Samia Harbi, et al.
European Journal of Haematology|August 12, 2024
Venetoclax-based non-intensive induction followed by allogenic stem-cell transplantation in elderly acute myeloid leukemia patients with adverse cytogeneticsAmel Soua, Julia Gilhodes, Alexandre Iat, et al.
Blood Advances|May 24, 2024
Low frequency of Vγ9Vδ2 T cells predicts poor survival in newly diagnosed acute myeloid leukemiaAnne-Charlotte Le Floch, Florence Orlanducci, Marie-Christine Béné, et al.
Blood|August 11, 2011
Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trialThorsten Braun, Raphael Itzykson, Aline Renneville, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2012
Clofarabine plus cytarabine compared with cytarabine alone in older patients with relapsed or refractory acute myelogenous leukemia: results from the CLASSIC I TrialStefan Faderl, Meir Wetzler, David Rizzieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2013
Prognostic score including gene mutations in chronic myelomonocytic leukemiaRaphaël Itzykson, Olivier Kosmider, Aline Renneville, et al.
Pageof 26

Showing results (191-200 of 251) with videos related to

Sort By:
Pageof 26
Leukemia Research|December 20, 2014
Azacitidine for the treatment of relapsed and refractory AML in older patientsRaphael Itzykson, Sylvain Thépot, Céline Berthon, et al.
The New England Journal of Medicine|September 15, 2016
Rituximab in B-Lineage Adult Acute Lymphoblastic LeukemiaSébastien Maury, Sylvie Chevret, Xavier Thomas, et al.
Blood Cancer Journal|January 27, 2022
Clinico-biological features of T-cell acute lymphoblastic leukemia with fusion proteinsThomas Steimlé, Marie-Emilie Dourthe, Marion Alcantara, et al.
European Journal of Haematology|March 18, 2021
Conventional chemotherapy for acute myeloid leukemia in older adults: Impact on nutritional, cognitive, and functional statusClaire Jouzier, Jean-François Hamel, Pierre-Yves Dumas, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 26, 2019
Thiotepa, Fludarabine, and Busulfan Conditioning Regimen before T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia: A Bicentric Experience of 100 PatientsThomas Pagliardini, Lucas Castagna, Samia Harbi, et al.
European Journal of Haematology|August 12, 2024
Venetoclax-based non-intensive induction followed by allogenic stem-cell transplantation in elderly acute myeloid leukemia patients with adverse cytogeneticsAmel Soua, Julia Gilhodes, Alexandre Iat, et al.
Blood Advances|May 24, 2024
Low frequency of Vγ9Vδ2 T cells predicts poor survival in newly diagnosed acute myeloid leukemiaAnne-Charlotte Le Floch, Florence Orlanducci, Marie-Christine Béné, et al.
Blood|August 11, 2011
Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trialThorsten Braun, Raphael Itzykson, Aline Renneville, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2012
Clofarabine plus cytarabine compared with cytarabine alone in older patients with relapsed or refractory acute myelogenous leukemia: results from the CLASSIC I TrialStefan Faderl, Meir Wetzler, David Rizzieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2013
Prognostic score including gene mutations in chronic myelomonocytic leukemiaRaphaël Itzykson, Olivier Kosmider, Aline Renneville, et al.
Pageof 26